Shuttle Pharmaceuticals Inc (SHPH) - יחס רווח גולמי

Shuttle Pharmaceuticals relies on US centers for the development of sensitizers for head and neck tumor therapy. This chart of gross margin values provided by GURU.Markets confirms the efficiency of the model, where 0.00 becomes the new value for this metric. High pricing power is driven by the critical necessity of the treatment, while ownership of all molecular formulas eliminates risks associated with outsourcing clinical trials.
פילוחי מדדים מקיפים ואנליטיקה עבור Shuttle Pharmaceuticals (SHPH)

Gross margin determines the efficiency of direct cost management by measuring the portion of revenue remaining after the cost of goods sold. For Shuttle Pharmaceuticals (SHPH), this indicator is critical, as the absence of stable cash flows makes the company dependent on the success of clinical drug trials. The gross margin trend on this chart allows for the real-time tracking of operating profit potential and the sustainability of the current business model.